Internal Medicine, Infectious Disease · Montgomery, AL
NPI
1407053150
Since 2007
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
2055 E South Blvd, Suite 202
Montgomery, AL, 36116
Phone (334) 284-5211
Groups this clinician bills Medicare through
Medicare paid, 2024
$37K
461 services
Medicare patients, 2024
130
Average age 72
Drug cost, 2024
$2.8M
1,633 prescriptions
Company payments, 2025
$14.19
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jyoti S Samant was code 99232 (hospital e&m - subsequent), 142 times for 59 patients. In total Jyoti S Samant billed 461 services in 23 codes, and Medicare paid $37K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-01-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 142 | 59 | $60.92 | $8,651 |
| 99214 Office E&M - Established | Office | 113 | 54 | $87.18 | $9,851 |
| 99233 Hospital E&M - Subsequent | Facility | 68 | 33 | $92.61 | $6,297 |
| 99223 Hospital E&M - Initial | Facility | 47 | 42 | $135.46 | $6,366 |
| 99238 Hospital Discharge Management | Facility | 23 | 21 | $63.11 | $1,452 |
By year: 2022 $44K for 601 services; 2023 $49K for 628 services; 2024 $37K for 461 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jyoti S Samant prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 211 prescriptions and refills. In total Jyoti S Samant wrote 1,633 Medicare prescriptions that cost $2.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 211 | 235 | 27 | $961K |
| Odefsey Emtricitab/Rilpiviri/Tenof Ala | 161 | 197 | 19 | $706K |
| Symtuza Darunavir/Cob/Emtri/Tenof Alaf | 66 | 80 | Under 11 | $379K |
| Dovato Dolutegravir Sodium/Lamivudine | 61 | 66 | Under 11 | $207K |
| Atorvastatin Calcium Generic | 59 | 161 | 33 | $717 |
| Ertapenem Ertapenem Sodium | 52 | 52 | 12 | $28K |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 52 | 126 | 21 | $4,107 |
| Juluca Dolutegravir/Rilpivirine | 51 | 51 | Under 11 | $183K |
| Doxycycline Hyclate Generic | 48 | 108 | 19 | $4,810 |
| Vancomycin Hcl Generic | 45 | 45 | Under 11 | $5,972 |
| Ciprofloxacin Hcl Generic | 40 | 81 | 21 | $2,110 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 35 | 78 | 14 | $4,637 |
| Tivicay Dolutegravir Sodium | 34 | 34 | Under 11 | $79K |
| Cephalexin Generic | 33 | 75 | 15 | $935 |
| Piperacillin-Tazobactam Piperacillin Sodium/Tazobactam | 24 | 24 | Under 11 | $5,901 |
Brand drugs: 753 claims; generic drugs: 868 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jyoti S Samant $14.19 ($14.19 in general payments such as food, travel and fees) from 1 company. The largest payer was Gilead Sciences, Inc. with $14.19.
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. GILD | 1 | $14.19 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.